Preferred Name |
Lipoatrophy |
|
Synonyms |
Loss of fat tissue in localised area Loss of fat tissue in localized area Atrophy of fat |
|
Definitions |
This may occur as a result of subcutanous injections of insulin in the treatment of diabetes, from the use of human growth hormone or from subcutanous injections of Copaxone used for the treatment of multiple sclerosis. In the latter case, an injection may produce a small dent at the injection site. Lipoatrophy is also an adverse drug reaction that is associated with some antiretroviral drugs. Localized loss of fat tissue. |
|
ID |
http://purl.obolibrary.org/obo/HP_0100578 |
|
comment |
This may occur as a result of subcutanous injections of insulin in the treatment of diabetes, from the use of human growth hormone or from subcutanous injections of Copaxone used for the treatment of multiple sclerosis. In the latter case, an injection may produce a small dent at the injection site. Lipoatrophy is also an adverse drug reaction that is associated with some antiretroviral drugs. |
|
creation_date |
2010-12-27T12:55:33Z |
|
creator | ||
database_cross_reference |
UMLS:C1280433 MEDDRA:10024604 SNOMEDCT_US:248315005 |
|
definition |
Localized loss of fat tissue. |
|
gwas_trait |
true |
|
has_exact_synonym |
Loss of fat tissue in localised area Loss of fat tissue in localized area Atrophy of fat |
|
id |
HP:0100578 |
|
in_subset | ||
label |
Lipoatrophy |
|
notation |
HP:0100578 |
|
prefLabel |
Lipoatrophy |
|
subClassOf |